Chemist Warehouse duo to climb Rich List after Sigma deal
Chemist Warehouse’s two billionaire founders, Jack Gance and Mario Verrocchi, are set to climb several rungs up the Financial Review Rich List if they pull off their proposed merger with ASX-listed Sigma Healthcare.
Documents associated with the merger, which will create an $8.8 billion giant with more than 1000 company-owned or franchised pharmacies, show for the first time the precise shareholdings of Mr Gance and Mr Verrocchi, who founded the entity that became Chemist Warehouse in 1995.
Mr Verrocchi will hold 2.57 million escrowed shares or 22.3 per cent of shares in the merged company upon completion, while Mr Gance will hold 1.61 million escrowed (13.9 per cent). His younger brother, Sam Gance, will hold 1.47 million escrowed shares (12.8 per cent).
The Rich List research team has estimated that Mr Gance and family, including his brother, now have wealth of $3.28 billion, up from the $2.38 billion appraisal published in June. Meanwhile, the estimate for Mr Verrocchi and family is $3.16 billion, up from $2.35 billion.
This would move Mr Gance and Mr Verrocchi up roughly 10 places from their respective 51st and 52nd showing on this year’s list.
The valuations of both have been buoyed by the $700 million cash consideration which formed part of Chemist Warehouse’s acquisition by Sigma, in addition to the shares in the merged company they will hold. Underpinning the valuations are the generous dividends paid to Chemist Warehouse’s shareholders, including $645 million in the last two years.
The founding families have extensive property interests outside Chemist Warehouse too. The documents lodged for the merger reveal that Chemist Warehouse directors own properties for which the group paid them $32 million in rents in the last financial year.
Investment banker David Di Pilla may also be knocking on the door of the Rich List, following his role as kingmaker in the deal. His HMC Capital owned 19 per cent of Sigma going into the merger with Chemist Warehouse, where his sister Danielle was a franchisee, and will emerge with just under 3 per cent of the new company should the deal proceed.
As with Chemist Warehouse, however, HMC Capital is an unlisted public company and Di Pilla’s individual holding in the entity is unclear. His earlier success with Home Consortium, the former Woolworths Masters properties, had him just below the cut-off on previous Rich Lists.
Trained pharmacists
The precise holdings of other members of the Gance and Verrocchi families have not been disclosed in documents lodged with the ASX.
However, several members of both families are trained pharmacists and own outlets in their own right. This proved a handy fillip for growth in Chemist Warehouse’s early days, given ongoing restrictions against non-pharmacists owning pharmacies, and limits in most states and territories on how many pharmacies an individual can control.
Sam Gance’s son Damien Gance is a pharmacist and Chemist Warehouse’s long-time commercial director. Mr Verrocchi has two younger brothers, Adrian and Marcello, who are both also pharmacists.
It is possible that these siblings will own a significant proportion of the 4.25 million shares in the proposed merger attributed to other, non-escrowed former Chemist Warehouse shareholders.
Mr Gance opened his first pharmacy in Reservoir in Melbourne’s north in 1972, and hired Mr Verrocchi in 1980 because he could speak Italian, which was then the predominant language in pockets of the area.
The entrepreneurial Mr Gance later used his small chain of pharmacies to bring the Le Specs and Le Tan brands to Australia, selling that distribution business in 1991. The Gances and the Verrocchi family bought the shell of a friendly society and began exploiting a loophole in Victorian law that placed no limit on how many pharmacies a friendly society could own.
That loophole closed in the mid-2000s, after which the founders switched to a franchised model. Never popular with the pharmacy establishment, Chemist Warehouse ironically benefited from the Pharmacy Guild’s lobbying which has kept the major supermarkets out of the business.
Read more about the pharmacy mega-deal
- Chemist Warehouse’s 100-year plan to be the next Walgreens Chemist Warehouse CEO Mario Verrocchi says the retailer could become the next Walgreens or Boots and expand rapidly overseas after becoming an $8.8 billion ASX-listed pharmacy giant.
- Chemist Warehouse’s boss targets growth of ‘infinity and beyond’ Mario Verrocchi, one of the billionaire founders of the pharmacy chain, says international expansion will be a key focus for the company as it joins the ASX.
- How David Di Pilla dreamt up the Chemist Warehouse deal over sushi Five months ago, over a sushi dinner at Melbourne’s Nobu, Sigma boss Vikesh Ramsunder and his major shareholder David Di Pilla were toasting a win. Then the lightbulb moment hit.
- Chanticleer | The 100-year dream that powers Chemist Warehouse The company is on the verge of achieving a 50-year dream with the $8.8 billion Sigma merger. It insists there’s plenty of growth to come.
- Chanticleer | Is the backdoor the new way to the ASX boards? If Chemist Warehouse can do it, what’s stopping Virgin Australia backdoor listing via Rex? Or MolyCop via Monadelphous? The IPO game has taken an interesting twist.
- Chanticleer | Chemist Warehouse deal will make Sigma stock a global attraction The deal name, Project Orbit, says it all. Hats off to this sleepy wholesaler for rocketing into the large-cap universe and catching the eye of US giants.
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In People
Fetching latest articles